Hippocampus and locus coeruleus activity on rats chronically treated with diazepam

Pharmacology Biochemistry and Behavior

Volumn 69, Issue 3-4, 2001, Pages 431-438

  Pérez, Mariela F ^a   Nasif, Fernando J ^a   Marchesini, Gerardo R ^a   Maglio, Laura E ^a   Ramirez, Oscar A ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Benzodiazepine; Dependence; Hippocampus; Locus coeruleus; Noradrenergic transmission; Synaptic plasticity; Withdrawal

Indexed keywords

DIAZEPAM; NORADRENALIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN NERVE CELL; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; DRUG WITHDRAWAL; HIPPOCAMPUS; LOCUS CERULEUS; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE;

ANIMALS; DIAZEPAM; GABA MODULATORS; HIPPOCAMPUS; LOCUS COERULEUS; LONG-TERM POTENTIATION; MALE; RATS; RATS, WISTAR;

EID: 0034882468     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00517-2     Document Type: Article

References (71)

1. Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons
2. Impaired learning and decreased cortical norepinephrine after bilateral locus coeruleus lesions
3. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle
4. Conditioned response of monkey locus coeruleus neurons anticipate acquisition of discriminative behavior in a vigilance task
5. Locus coeruleus, stress, and PTSD, neurobiological and clinical parallels
6. A synaptic model of memory: Long-term potentiation in the hippocampus
7. Reduction of voltage-dependent currents by ethanol contributes to inhibition of NMDA receptor-mediated excitatory synaptic transmission
8. Catecholamine receptors on locus coeruleus: Pharmacological characterization
9. 3H]dopamine release from mesencephalic cell cultures
10. Where is the locus in opioid withdrawal?
11. Memories of NMDA receptors and LTP
12. Decrease in GABAergic function induced by pentylenetetrazol kindling in rats: Antagonism by MK-801
13. The effect of some psychoactive drugs on central monoamine neurons
14. Minor tranquilizers, stress and central catecholamine neurons
15. Ethopharmacological analysis of rat behavior on the elevated plus-maze
16. Continuous slow release of low levels of diazepam produces tolerance to its depressant and anxiolytic effects on the startle reflex
17. Involvement of N-methyl-D-aspartate receptors in epileptiform bursting in the rat hippocampal slice
18. Changes in noradrenaline plasma levels and behavioural responses induced by benzodiazepine agonists with the benzodiazepine antagonist Ro 15-1778
19. Tolerance to the behavioral actions of benzodiazepines
20. The pharmacokinetics of diazepam and desmethyldiazepam in rat brain and plasma
21. MK-801 prevents the decrease in 35S-TBPS binding in the rat cerebral cortex induced by pentylenetetrazol kindling
22. Subacute benzodiazepine treatment: Observations on behavioural tolerance and withdrawal
23. Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats
24. Evaluation of the dependence potential of the selective 5-H1A agonist ipsapirone in rats and of its effects on benzodiazepine withdrawal
25. Effects of the CCKB antagonist L-365,260 on benzodiazepine withdrawal-induced hypophagia in rats
26. Evidence for a dissociation between benzodiazepine withdrawal signs
27. Benzodiazepine withdrawal phenomena
28. Long-term potentiation in the hippocampus involves activation of N-methyl-D-aspartate receptors
29. Norepinephrine promotes long-term potentiation in the adult rat hippocampus in vitro
30. 3H]glutamate binding during pentobarbital tolerance and withdrawal in the rat
31. Activation of locus coeruleus by prefrontal cortex is mediated by excitatory amino acid inputs
32. Drugs of abuse: Anatomy, pharmacology and function of reward pathways
33. Reversal by alpha-2 agonists of diazepam withdrawal hyperactivity in rats
34. A/benzodiazepine receptor heterogeneity: Neurophysiological implications
35. Rapid tolerance to benzodiazepine modifies rat hippocampal synaptic plasticity
36. Drug addiction: A model for the molecular basis of neural plasticity
37. Molecular and cellular mechanisms of opiate action: Studies in the rat locus coeruleus
38. Benzodiazepines, plasma MHPG and alpha-2-adrenoceptor function in man
39. 3H]phorbol dibutyrate binding to protein kinase C in pentobarbital tolerant/dependent rats
40. Muscimol prevents neuronal injury induced by NMDA
41. Benzodiazepine dependence. A review of the evidence
42. Chronic stress - Induce changes in locus coeruleus neuronal activity
43. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat
44. The benzodiazepine withdrawal syndrome
45. Benzodiazepine dependence
46. Possible involvement of NMDA receptor-mediated transmission in barbiturate physical dependence
47. From ion currents to genomic analysis: Recent advances in GABAA receptor research
48. Locus coeruleus norepinephrine-containing neurons: Effects produced by acute and subchronic treatment with antipsychotic drugs and amphetamine
49. Electrophysiological evidence for locus coeruleus norepinephrine autoreceptor subsensitivity following subchronic administration of D-amphetamine
50. Differential threshold for long-term potentiation in the hippocampus of rats with inborn high or low learning capacity
51. The CCK-B antagonist LY288513 blocks diazepam-withdrawal-induced increases in auditory startle response
52. Evidence for the role of brain norepinephrine and dopamine in "rebound" phenomenon seen during withdrawal after repeated exposure to benzodiazepines
53. Some neurochemical correlates of "rebound" phenomenon observed during withdrawal after long-term exposure to 1,4-benzodiazepines
54. Studies of the nucleus locus coeruleus in monkeys and hypotheses for neuropsychopharmacology
55. Long-term diazepam therapy and clinical outcome
56. Central norepinephrine neurons and behavior
57. Structure and pharmacology of gamma-aminobutyric acid A receptor subtypes
58. A receptors
59. Blockade of norepinephrine-induced long-lasting potentiation in the hippocampal dentate gyrus by an inhibitor of protein synthesis
60. Activation of NMDA receptors blocks GABAergic inhibition in an in vitro model of epilepsy
61. Differential coupling of GABA-A and GABA-B receptors to the noradrenergic system
62. Long-term potentiation
63. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801
64. Role of the NMDA receptor complex in DMCM-induced seizure in mice
65. Recovery of decreased seizure threshold for pentylenetetrazole during diazepam withdrawal by NMDA receptor antagonists
66. NMDA receptor antagonists potently suppress the spontaneous withdrawal signs induced by discontinuation of long-term diazepam treatment in Fischer 344 rats
67. Facilitation of acquisition and extinction of an operant task four weeks after stimulation of brainstem aminergic nuclei of the rat
68. Abuse liability of benzodiazepines
69. Benzodiazepines: Use, abuse, and consequences
70. Region specific expression of NMDA receptor NR1 subunit mRNA in hypothalamus and following chronic morphine treatment